Comparison between JFL Life Sciences IPO and Olatech Solutions IPO.
JFL Life Sciences IPO is a SME Fixed Price IPO proposed to list at NSE SME while Olatech Solutions IPO is a SME Fixed Price proposed to list at BSE SME.
| JFL Life Sciences IPO | Olatech Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Shreni Shares Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Econo Broking Pvt.Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of JFL Life Sciences IPO is up to ₹17.25 Cr whereas the issue size of the Olatech Solutions IPO is up to ₹1.77 Cr. The final issue price of JFL Life Sciences IPO is ₹61.00 per share and of Olatech Solutions IPO is ₹27.00 per share.
| JFL Life Sciences IPO | Olatech Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹61.00 per share | ₹27.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 28,28,000 shares | 6,56,000 shares |
| Fresh Issue Size (Amount) | up to ₹17.25 Cr | up to ₹1.77 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 28,28,000 shares | 6,56,000 shares |
| Issue Size Total (Amount) | up to ₹17.25 Cr | up to ₹1.77 Cr |
JFL Life Sciences IPO opens on Aug 25, 2022, while Olatech Solutions IPO opens on Aug 12, 2022. The closing date of JFL Life Sciences IPO and Olatech Solutions IPO is Aug 30, 2022, and Aug 19, 2022, respectively.
| JFL Life Sciences IPO | Olatech Solutions IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Aug 12, 2022 |
| Issue Close | Aug 30, 2022 | Aug 19, 2022 |
| Basis Of Allotment (Tentative) | Sep 05, 2022 | Aug 24, 2022 |
| Initiation of Refunds (Tentative) | Sep 06, 2022 | Aug 25, 2022 |
| Credit of Share (Tentative) | Sep 07, 2022 | Aug 26, 2022 |
| Listing date (Tentative) | Sep 08, 2022 | Aug 29, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
JFL Life Sciences IPO P/E ratio is 26.52, as compared to Olatech Solutions IPO P/E ratio of 18.
| JFL Life Sciences IPO | Olatech Solutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.52 | 92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.47 | 64.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.52 | 18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹67.09 Cr. | ₹6.32 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the JFL Life Sciences IPO Retail Individual Investors (RII) are offered 14,14,000 shares while in Olatech Solutions IPO retail investors are offered 14,14,000 shares. Qualified Institutional Buyers (QIB) are offered in JFL Life Sciences IPO and in Olatech Solutions IPO.
| JFL Life Sciences IPO | Olatech Solutions IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,50,000 shares | 44,000 shares |
| QIB | ||
| NII | 14,14,000 shares | 3,28,000 shares |
| RII | 14,14,000 shares | 3,28,000 shares |
| Employee | ||
| Others | ||
| Total | 28,28,000 shares | 6,56,000 shares |
JFL Life Sciences IPO subscribed 8.93x in total, whereas Olatech Solutions IPO subscribed 598.82x.
| JFL Life Sciences IPO | Olatech Solutions IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 6.19x | 517.71x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.66x | 679.94x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.93x | 598.82x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
